The cost of Valsartan experienced a significant rise in May, continuing the upward trend seen in the previous month. This increase is attributed to various factors such as increased consumer demand, supply chain challenges, and limited market availability. Moreover, market stakeholders were actively replenishing their stocks after the first quarter, further fuelling the already high demand and contributing to the upward pressure on Valsartan prices.

In China, manufacturing sector experienced an unexpected slowdown in May, evidenced by a drop in the official manufacturing Purchasing Managers' Index (PMI) from 50.4 in April to 49.5, as mentioned by the National Bureau of Statistics (NBS). This deceleration was partially due to the Labor Day holidays in early May, which constrained supply in the domestic market compared to demand. As a result, this imbalance led to a rise in Valsartan prices.

Given China's pivotal role as a major exporter of Active Pharmaceutical Ingredients (APIs), a similar trend in Valsartan prices was observed in Western markets. Despite ongoing inflation and high interest rates, the U.S. economy has demonstrated resilience in 2024. However, the Federal Reserve (Fed) remains committed to cooling the economy and reducing inflation. While the target inflation rate is 2%, it currently persists above 3%, which is considered too elevated. In May, consumer confidence in the U.S. rebounded following three consecutive months of decline, bolstering consumer spending and influencing the rise in Valsartan prices.

Concurrently, the eurozone experienced an upturn in economic activity in May, characterized by significant expansions in business operations and new orders, particularly during the second quarter. This surge in economic activity heightened the demand for Valsartan among end-users, thereby pushing prices upwards. Many businesses had initially reduced their inventories, expecting subdued consumer demand amid economic uncertainties. However, with consumer demand proving stronger than anticipated, these businesses are now swiftly replenishing their stocks, further contributing to the upward trajectory of Valsartan prices.

Moreover, the situation in the Red Sea has become more intricate, with recent attacks spreading further into offshore areas. Consequently, vessels are now required to extend their routes, resulting in heightened expenses and longer travel durations. Many ships are taking detours, which add between 7 to 14 days to their voyages. This shift has led to increased port fees, congested shipping lanes, and disruptions in the dynamics of container supply and demand. These combined factors contribute significantly to the rising costs of Valsartan.

According to ChemAnalyst, the prices of Valsartan are forecasted to keep rising in the coming months, driven by the expected global easing of monetary policies which is likely to stimulate demand across different end-user sectors. However, this projection is subject to several risks, including uncertain prospects for advanced economies, geopolitical tensions, the ongoing crisis in the Middle East exacerbating issues in the Red Sea, and increasing geo-economic divisions. These external factors introduce uncertainties and potential challenges that could influence the direction of Valsartan prices in the near term.